Key result
Mesenchymal Gja1 deletion partially protects mice against high-fat diet-induced weight gain and metabolic syndrome.
Why the study?
The role of Connexin43 in mesenchymal lineage cells in regulating body adiposity and energy metabolism was not fully understood.
Does genetic deletion of Gja1 in mesenchymal lineage cells prevent weight gain and metabolic syndrome in mice on a high fat diet?
Does genetic deletion of Gja1 in mesenchymal lineage cells prevent weight gain and metabolic syndrome in mice on a high fat diet?
p-value: p=<0.001
Connexin43 in adipocyte progenitors regulates energy expenditure and fat accumulation, presenting a potential pharmacologic target for improving metabolic balance in diabetes and obesity.
Identifies Connexin43 in adipocyte progenitors as a metabolic regulator; hypothesis-generating for obesity therapies with human translation untested.
Connexin43 (Cx43) is the most abundant gap junction protein present in the mesenchymal lineage. In mature adipocytes, Cx43 mediates white adipose tissue (WAT) “beiging” in response to cold exposure and maintains the mitochondrial integrity of brown adipose tissue (BAT). We found that genetic deletion of Gja1 (Cx43 gene) in cells that give rise to chondro-osteogenic and adipogenic precursors driven by the Dermo1/Twist2 promoter leads to lower body adiposity and partial protection against the weight gain and metabolic syndrome induced by a high fat diet (HFD) in both sexes. These protective effects from obesogenic diet are related to increased locomotion, fuel utilization, energy expenditure, non-shivering thermogenesis, and better glucose tolerance in conditionally Gja1 ablated mice. Accordingly, Gja1 mutant mice exhibit reduced adipocyte hypertrophy, partially preserved insulin sensitivity, increased BAT lipolysis and decreased whitening under HFD. This metabolic phenotype is not reproduced with more restricted Gja1 ablation in differentiated adipocytes, suggesting that Cx43 has a hitherto unknown function in adipocyte progenitors or other targeted cells, resulting in restrained energy expenditures and fat accumulation. These results disclose an hitherto unknown action of Cx43 in adiposity, and offer a promising new pharmacologic target for improving metabolic balance in diabetes and obesity.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2024) studied Obesity and metabolic syndrome. Genetic deletion of Gja1 (Cx43 gene) in mesenchymal lineage cells vs. Wild type mice (Gja1flox/flox) was evaluated on Weight gain on high fat diet (p=<0.001). Genetic deletion of Gja1 in mesenchymal lineage cells partially protected mice against high fat diet-induced weight gain and metabolic syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: